LV11542A - Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxide-5,7, their uptake and application - Google Patents

Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxide-5,7, their uptake and application

Info

Publication number
LV11542A
LV11542A LV950084A LV950084A LV11542A LV 11542 A LV11542 A LV 11542A LV 950084 A LV950084 A LV 950084A LV 950084 A LV950084 A LV 950084A LV 11542 A LV11542 A LV 11542A
Authority
LV
Latvia
Prior art keywords
tetraazaundecadien
tetraoxa
uptake
dioxide
substituted
Prior art date
Application number
LV950084A
Other languages
Latvian (lv)
Other versions
LV11542B (en
Inventor
Janis Kuzmanis
Ivars Kalvins
Original Assignee
Latvijas Organiskas Sintezes Instituts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskas Sintezes Instituts filed Critical Latvijas Organiskas Sintezes Instituts
Priority to LVP-95-84A priority Critical patent/LV11542B/en
Priority to PCT/LV1996/000001 priority patent/WO1996030336A1/en
Publication of LV11542A publication Critical patent/LV11542A/en
Publication of LV11542B publication Critical patent/LV11542B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/08—Azoxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-95-84A 1995-03-30 1995-03-30 Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof LV11542B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-95-84A LV11542B (en) 1995-03-30 1995-03-30 Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof
PCT/LV1996/000001 WO1996030336A1 (en) 1995-03-30 1996-03-19 Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadiene-4,7-dioxides-5,7, their preparation and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-95-84A LV11542B (en) 1995-03-30 1995-03-30 Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof

Publications (2)

Publication Number Publication Date
LV11542A true LV11542A (en) 1996-10-20
LV11542B LV11542B (en) 1997-02-20

Family

ID=19735911

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-84A LV11542B (en) 1995-03-30 1995-03-30 Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof

Country Status (2)

Country Link
LV (1) LV11542B (en)
WO (1) WO1996030336A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678391B2 (en) 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
EP1502604A1 (en) * 2000-04-26 2005-02-02 Cellegy Pharmaceuticals, Inc Use of nitric oxide mimetics in cancer treatment
WO2001080890A2 (en) 2000-04-26 2001-11-01 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
CA2478145A1 (en) * 2002-03-06 2003-09-12 Cellegy Pharmaceuticals, Inc. Formulations and methods of using nitric oxide mimetics in cancer treatment
DE10358077A1 (en) * 2003-12-10 2005-07-28 Georg Bauer Method for increasing the sensitivity of tumor cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3969793A (en) * 1992-04-13 1993-11-18 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of nitric oxide/nucleophile complexes for the treatment of cancer
US5374710A (en) * 1993-05-26 1994-12-20 Regents Of The University Of California Compounds which release nitric oxide upon illumination

Also Published As

Publication number Publication date
WO1996030336A1 (en) 1996-10-03
LV11542B (en) 1997-02-20

Similar Documents

Publication Publication Date Title
DE59605821D1 (en) 1/4 SCALLABSORBER
DK0653179T3 (en) Several had to
DK0771789T3 (en) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
FI951018A0 (en) Hoeghastighetsdataoeverfoering i mobiltelesystem
BR9607058A (en) Composition
BR9606809A (en) Insecticide-active composition
DK0759469T3 (en) bacteriocin
BR9609884A (en) N-aryl- 1,2,4-triazolin-5-ones
DE69601423D1 (en) BADMINTON
DE69618634D1 (en) 1,4-benzodioxin-DERIVATIVES
PT728814E (en) BETUMINOUS COMPOSITION
BR9609903A (en) Insecticide-active composition
DE69616374D1 (en) GERMIZIDE COMPOSITION
NO960353L (en) 4 aminobenzoylguanidinderivater
LV11542A (en) Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxide-5,7, their uptake and application
BR9607946A (en) Composition
NO960392D0 (en) 4 merkaptobenzoylguanidinderivater
BR9603032A (en) Pesticide composition
NO962931D0 (en) N, N-Diethyl-8,8-dipropyl-2-azaspiro [4,5Ådecan-2-propanamindimaleat
BR9610047A (en) 1,3,4-oxadiazolin-2-ones
SE9501297D0 (en) Dermatological composition
SE9501893D0 (en) Section 1
UA10890A (en) MICROICHECTOR
UA1150S (en) DICE-ALPHABET GAME "PICTOGRAMS-HEALTH"
FI2204U1 (en) Lyftmekanism Foer en saekerhetskant i en Saeng